Meyka Pro banner
Neumora Therapeutics, Inc. Common Stock

Why Is Neumora Therapeutics, Inc. Common Stock (NASDAQ: NMRA) Stock Down Today?

Live update on NMRA's movement on the NASDAQ, with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.

NMRANASDAQ
HealthcareBiotechnology
$1.66
$0.17(11.41%)
U.S. Market opens in 14h 25m

NMRA is Up +11.41% today

You might want to check out Why is NMRA Up Today?

Neumora Therapeutics, Inc. Common Stock (NASDAQ: NMRA) Update

Volume (Unusual)
811.07K
63.00%
Open / Previous Close
$1.51 / $1.49
Day Range (Low / High)
$1.50 - $1.71

Neumora Therapeutics, Inc. Common Stock (NASDAQ: NMRA) Summary

Neumora Therapeutics, Inc. Common Stock (NASDAQ: NMRA) is trading up +11.41% at $1.66, reflecting a positive shift in investor sentiment today. The stock opened at $1.51 and has moved between $1.50 and $1.71 so far.

Trading volume is 811071, which is 63% below its average, and the price action suggests buying interest.

Technically, NMRA on the NASDAQ is trading below its 50-day moving average of $1.66 and below its 200-day moving average of $2.18, indicating short-term and long-term weakness.

Analyst sentiment is bullish. Meyka's AI assigns NMRA a grade of B (Overall moderate), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -62.65% in 1 month ($0.62), +67.22% in 1 year ($2.78), and +286.70% in 5 years ($6.42).

See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.

NMRA (NASDAQ) Technical Signals

Trading below 50-day moving average ($1.66)

Trading below 200-day moving average ($2.18)

Analyst Recommendations (NASDAQ: NMRA)

Strong Buy
0
Buy
3
Hold
0
Sell
0
Strong Sell
0

Price Forecast

1 Month

$0.62

1 Year

$2.78

3 Years

$4.61

5 Years

$6.42

B
Good61.00

Is this change significant?

5-Day:+4.40%

1-Month:+1.22%

3-Month:-25.23%

What's next?

Next earnings date: 7/30/2025

Frequently Asked Questions